Today, the centre approved two additional vaccines and one antiviral medicine to help battle the COVID-19 pandemic. Corbevax and Covovax are the two most recent vaccinations approved by India. Health Minister Mansukh Mandaviya tweeted this morning that the antiviral medicine Molnupiravir should only be used in an emergency.

According to the Health Minister, Corbevax is India’s first homegrown “RBD protein sub-unit vaccine.” Biological-E, a company based in Hyderabad, created it. “It’s a three-peat! It is India’s third vaccine to be developed “Mr Mandaviya expressed his thoughts. Bharat Biotech’s Covaxin and the Serum Institute of India’s Covishield are the other two vaccines developed in India.

SII, situated in Pune, will manufacture the nanoparticle vaccine Covovax.

Molnupiravir, an antiviral medication, will be manufactured in India by 13 businesses for limited usage in emergency situations to treat adult patients with COVID-19 who are at high risk of disease progression, according to the Health Minister.

Covishield, Covaxin, ZyCoV-D, Sputnik V, Moderna, Johnson & Johnson, Corbevax, and Covovax are among the eight COVID-19 vaccines that have received emergency use authorization from India’s pharma authority.

Dr. Reddy’s Laboratories, in collaboration with Cipla, Mylan, Torrent, Emcure, and Sun Pharma, submitted a proposal for the approval of the antiviral drug Molnupiravir for emergency use.

The Shining Media

The Shining Media is an independent news website and channel, covering updates from the world of Politics, Entertainment, Sports, International, National, and a lot more.

By The Shining Media

The Shining Media is an independent news website and channel, covering updates from the world of Politics, Entertainment, Sports, International, National, and a lot more.

Leave a Reply

Your email address will not be published.